2238 Waldman, Scott - Jefferson Medical College - Thomas Jefferson University
saw103

Scott A. Waldman, MD, PhD

Contact Dr. Waldman

132 South Tenth Street
1170 Main Building
Philadelphia, PA 19107

(215) 955-6086
(215) 955-5681 fax

Most Recent Peer-reviewed Publications

  1. Systems-based discovery advances drug development
  2. Translational medicine individualizes healthcare discovery, development and delivery
  3. Obesity pharmacotherapy: What is next?
  4. Immunotherapeutic strategies to target prognostic and predictive markers of cancer
  5. Guanylyl cyclase C as a biomarker in colorectal cancer
  6. GUCY2C: at the intersection of obesity and cancer
  7. Advancing pharmacometrics and systems pharmacology
  8. Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer
  9. Phosphorylation of vasodilator-stimulated phosphoprotein Ser239 suppresses filopodia and invadopodia in colon cancer
  10. GUCY2C molecular staging personalizes colorectal cancer patient management
  11. Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C
  12. Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes
  13. Molecular staging individualizing cancer management
  14. Clinical pharmacology therapeutics 2011: Year in review
  15. GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity
  16. The Value Proposition of Molecular Medicine
  17. Knowledge cycle transforms therapeutic innovation
  18. GUCY2C-targeted cancer immu 03FF notherapy: Past, present and future
  19. Patient-centric clinical pharmacology advances the path to personalized medicine
  20. Cardiovascular health: The global challenge
0